Page last updated: 2024-12-08

ribitol-5-phosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

D-ribitol 5-phosphate : The 5-phospho derivative of D-ribitol. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID151104
CHEBI ID16051
CHEBI ID16246
SCHEMBL ID638724
MeSH IDM0121843

Synonyms (26)

Synonym
CHEBI:16051
5-o-phosphono-d-ribitol
rbt-5-p
d-ribitol 5-(dihydrogen phosphate)
CHEBI:16246
l-ribitol 1-phosphate
C01068
d-ribitol 5-phosphate
ribitol 5-phosphate
[(2r,3s,4s)-2,3,4,5-tetrahydroxypentyl] dihydrogen phosphate
3506-18-1
ribitol-5-phosphate
ribitol, 1-(dihydrogen phosphate)
ribitol, phosphate, d-
ribitol phosphate
d-ribitol, 5-(dihydrogen phosphate)
0BA496N6TQ ,
SCHEMBL638724
VJDOAZKNBQCAGE-LMVFSUKVSA-N
d-ribitol-5-phosphate
35320-17-3
AC-33212
DTXSID30188562
unii-0ba496n6tq
Q27101813
{[(2r,3s,4s)-2,3,4,5-tetrahydroxypentyl]oxy}phosphonic acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
ribitol 5-phosphate
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (10.00)18.7374
1990's0 (0.00)18.2507
2000's5 (25.00)29.6817
2010's10 (50.00)24.3611
2020's3 (15.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.16

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.16 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index4.57 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (19.16)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (10.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (90.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]